SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 3, 2003
Natus Medical Incorporated
(Exact name of registrant as specified in its charter)
Delaware |
000-33001 |
77-0154833 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1501 Industrial Road, San Carlos, California |
94070 | |
(Address of principal executive offices) |
(Zip Code) |
Registrants telephone number, including area code: (650) 802-0400
Not applicable
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS AND REQUIRED REGULATION FD DISCLOSURE.
On June 3, 2003, Natus Medical Incorporated (the Company) issued a press release regarding the appointment of Steven J. Murphy as vice president, finance and the resignation of Glenn A. Bauer, its chief financial officer. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
Exhibit No. |
Description | |
99.1 |
Press release dated June 3, 2003. |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NATUS MEDICAL INCORPORATED | ||||||
Dated: June 9, 2003 |
By: |
/s/ Tim C. Johnson | ||||
Tim C. Johnson President, Chief Executive Officer and Chief Operating Officer |
-3-
Index to Exhibits
Exhibit No. |
Description | |
99.1 |
Press release dated June 3, 2003. |
-4-